Consun Pharmaceutical (HKG:1681) unit Guangzhou Consun Pharmaceutical agreed to invest 191.4 million yuan in Shanghai Huamao Pharmaceutical for a 30% stake, according to a Monday Hong Kong bourse filing.
The investment will be made through the purchase of existing equity interest and a capital increase in cash.
Shanghai Huamao Pharmaceutical is a biotechnology and pharmaceutical company and acts as a supplier of Consun Pharmaceutical.
The purchase will facilitate market expansion, vertical integration, supply strengthening, and R&D resource sharing for the firm among other benefits.